Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 281.00
0.00 (0.00%)
Aug 17, 2026, 4:35 PM GMT
AIM:AMS Market Cap
AIM:AMS has a market cap or net worth of 609.2 million as of August 17, 2026. Its market cap has increased by 40.30% in one year.
Market Cap
609.20M
Enterprise Value
674.02M
Revenue
228.94M
Ranking
n/a
PE Ratio
62.17
Stock Price
281.00
ChartMarket Cap Chart
Since April 11, 2000, AIM:AMS's market cap has increased from 11.11M to 609.20M, an increase of 5,384.83%. That is a compound annual growth rate of 16.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 609.20M | 29.56% |
| Dec 31, 2025 | 470.21M | 11.01% |
| Dec 31, 2024 | 423.58M | -6.07% |
| Dec 29, 2023 | 450.96M | -19.69% |
| Dec 30, 2022 | 561.49M | -23.12% |
| Dec 31, 2021 | 730.32M | 39.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.75B |
| GSK plc | 72.83B |
| Haleon | 31.32B |
| Smith & Nephew | 9.22B |
| Oxford Nanopore Technologies | 1.19B |
| Spire Healthcare Group | 937.40M |
| CVS Group | 894.55M |
| Oxford Biomedica | 589.46M |